Thursday, 9 May 2019
Investorideas.com - North Dakota Eliminates Jail Time for Possession of Small Amounts of Marijuana
Investorideas.com - North Dakota Eliminates Jail Time for Possession of Small Amounts of Marijuana
www.investorideas.com - News that inspires big Ideas
www.investorideas.com - News that inspires big Ideas
Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (NYSE: $CGC) (TSXV: $RIV.V) (NYSE: $ACB) (CSE: $AHG.C) (CSE: $THC.C)
Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move-
(NYSE: $CGC) (TSXV: $RIV.V) (NYSE: $ACB) (CSE: $AHG.C) (CSE: $THC.C)
Delta, Kelowna, BC –May 9th,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/05091CGC-RIV-ACB-AHG-THC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast I look at a few of the day’s earlier announcements.
But
first, Gov. Doug Burgum has signed a bill into law making North
Dakota the 25th state in the nation to eliminate the threat of jail time for
possession of small amounts of marijuana.
HB 1050 reclassifies possession of up to a half ounce of
marijuana by adults 21 and older as an infraction punishable by no jail time
and a maximum fine of $1,000. Previously, it was a misdemeanor punishable by up
to 30 days in jail in addition to a fine. The bill also reclassifies penalties
for possession offenses involving amounts greater than a half ounce, and it
calls on the Legislative Assembly to “consider studying the implications of the
potential adoption of an initiated measure allowing the use of recreational
marijuana.” A more detailed summary of HB 1050 is available
here.
“This legislation is far from ideal, but it is a substantial
step in the right direction,” said Matthew Schweich, deputy director of the
Marijuana Policy Project. “It is very encouraging to see a conservative state
like North Dakota acknowledge and rectify the injustice of jailing people for
possession of small amounts of marijuana. Lawmakers can no longer ignore public
support for marijuana policy reform, which is growing quickly in every part of
the country.”
Gov. Burgum also recently signed a series of bills designed to
expand and improve access to medical marijuana for patients registered under
North Dakota’s existing medical marijuana law, which voters approved in 2016.
As
well, after the first year as a unified national industry association, and with
the framework of cannabis legalization firmly established, the Cannabis Council
of Canada has announced its newly elected Board of Directors. As
the association embarks on its second year of operations, the Board is tasked
with supporting its members and continuing to work with key stakeholders on the
advancement of the legal cannabis industry in Canada and around the world.
C3's
general membership represents almost 90% of Canada's legal cannabis industry,
and has elected the following individuals to the Board:
Megan McCrae – Aphria Inc., Board Chair
John Fowler – The Supreme Cannabis Company,
Vice Chair, Adult Use
Philippe Lucas – Tilray, Vice Chair,
Medical
Darren Karasiuk – Aurora Cannabis Inc.
Alison Gordon – 48 North Cannabis Co.
Jeff Jacobson – Cronos Group
Jeff Ryan – Canopy Growth Corporation
Ray Gracewood – Organigram
Isabelle Robillard – HEXO Corp.
Gerald Proctor – Sundial Growers Inc.
Ruth Chun – Newstrike/UP Cannabis
The
board members bring a wealth of diverse experience in the following areas:
scientific research, marketing and communications, strategy and innovation,
market analysis, business development, government relations, policy
development, law and non-profit.
Canopy Growth
Corporation (TSX: WEED) (NYSE: CGC) announced today that it has signed an offtake agreement
with PharmHouse Inc., a 49 per cent-owned joint venture of Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF). Under the terms of the agreement,
PharmHouse has agreed to allocate high quality cannabis flower from an
additional 20 per cent of the flowering space available at its Leamington
greenhouse facility over the next three years.
Boasting
1.3 million square feet of greenhouse grow space, and leveraging the resources
of Canopy Growth, Canopy Rivers and its joint venture partner have worked
diligently since October 2018 to prepare the facility for licensing. PharmHouse will leverage Canopy Growth's
genetics – selected and supplied by the Company – and flower will be returned
to the Company to be sold under Canopy Growth's diverse brands and
banners. Under the terms of the new offtake
agreement, PharmHouse is committed to producing GMP-certified, high quality
cannabis flower within 18 months of its cultivation license and the flower must
comply with the Company's high standards for cannabis quality. GMP, or Good
Manufacturing Practices, certification is the internationally recognized system
to ensure all produced goods meet the highest consumer health and safety
standards, allowing the Company to export the flower to its international
divisions. Including this new agreement, 30 per cent of PharmHouse's total
flowering space has been committed to Canopy Growth.
"We
have witnessed Canopy Rivers and its joint venture partner pour their hard work
into the PharmHouse facility in Leamington and couldn't be more satisfied with
how it has turned out," said Bruce Linton, Chairman & Co-CEO of Canopy
Growth Corporation and Chairman & CEO of Canopy Rivers. "We expect the
same for the flower quality that PharmHouse will be providing to Canopy Growth.
This is further evidence that the ecosystem model we had hoped for from Canopy
Rivers is demonstrating its value and this new offtake agreement with
PharmHouse speaks to how well we are managing our numerous assets."
Following that, one of America's most
influential tastemakers, best-selling author and business executive Martha
Stewart
will speak at the World Cannabis Congress (WCC)
in Saint John, NB being held this June 16-18. Stewart is an example of big brands
and high-profile personalities that are entering into the cannabis space as
outdated stigma gives way to mainstream growth opportunities.
"I
look forward to sharing my knowledge and experience in the lifestyle space with
this tailored audience," says Stewart. "As I begin to collaborate on
products for the CBD market, and as the demand for these types of product
grows, I'm very interested in the conversations and connections at this
event."
The
World Cannabis Congress is renowned for convening major influencers, thought
leaders, policy makers and government officials to help shape and advance the
cannabis industry worldwide. The curated, invite-only event is one of the most
sought-after tickets in the industry, bringing together the right people in the
right place at the right time to drive the industry forward. Stewart's
participation comes at a time when interest in CBD and cannabis-infused food
and beverages have become hot topics, with Canada set to legalize edibles later
this year.
"Martha
Stewart is the perfect example of where the cannabis industry is headed,"
says Derek Riedle, Publisher of Civilized. "This is an industry that's
quickly moved from the backroom to the boardroom. We're able to attract
phenomenal, top-tier talent and experts like Martha Stewart because of the
legitimacy the cannabis industry is amassing, as well as the calibre of the
audience we have in the room at WCC. We can't wait to hear what Martha Stewart
has to say about expanding her brand in this new market."
Aurora Cannabis
Inc. (TSX: ACB) (NYSE: ACB) announced today that the Company, through its wholly owned
subsidiary Aurora Deutschland, has been selected by the Luxembourg Health
Ministry as the exclusive supplier in a public bid to supply a second delivery
of medical cannabis to Luxembourg.
Under
the terms of the bid, the medical cannabis produced will be sold to
Luxembourg's Division de la Pharmacie et des Medicaments, representing the
second time the Company has received an order directly from the Luxembourg
government. While the initial bid quantities are small, the award confirms
Aurora's position as a trusted and preferred supplier to international jurisdictions
and reflects the Company's ability to work with local governments and
regulators in complex, restricted markets.
"We
are proud to continue serving as the exclusive supplier of medical cannabis to
the Luxembourg Health Ministry," said Neil Belot, Chief Global Business
Development Officer. "Adding to the many achievements of our European
team, which also includes our recent selection as one of only three companies
to establish domestic production in Germany, our expanded supply agreement with
Luxembourg reinforces Aurora's ability to act as a trusted partner that can
readily meet the complex needs of diverse international markets."
Alternate Health
Corp., (CSE:AHG) (OTCQB:AHGIF), an international leader in technology
and extraction solutions for the regulated cannabis industry, announced today a key step forward in the Company's
pharmaceutical-grade CBD product manufacturing strategy, having signed a joint
venture agreement with Oltecate Enterprises, a COFEPRIS-licensed Mexican CBD
distributor, with an eye for expansion throughout Latin America.
Alternate
Health's expansion into the Latin American CBD market complements the Company's
recent US$20 million acquisition of Blaine Labs, previously announced on May 5,
2019. With 23 years of experience producing FDA-approved and cGMP-certified
medical products, Blaine Labs is uniquely positioned to manufacture a wide
range of CBD products that meet international export standards. As Alternate
Health rapidly expands Blaine Labs CBD product line, the Company expects Mexico
to be a key growth market for future sales and a jumping off point for further
distribution throughout Latin America.
"With
this acquisition, we are taking another major step in consolidating the global
CBD market," says Howard Mann, CEO of Alternate Health. "We now boast
the addition of nation-wide Mexican CBD licenses to our hemp-based medical
product assets, including extraction, distribution and product
development."
Based
in Tecate, Baja California, Mexico, Oltecate's headquarters are strategically
located along the US-Mexican border with California. Oltecate currently holds
four federal CBD licenses issued by COFEPRIS, the Mexican equivalent of the
U.S. Food and Drug Administration (FDA). Currently, Mexican law prohibits
cannabis and hemp cultivation and extraction, but imports of CBD products are
legal with the appropriate COFEPRIS license. These licenses allow Alternate
Health to import and distribute products in numerous growing markets across
Mexico.
THC BioMed Intl
Ltd. (CSE: THC) THC BioMed reported that it has entered into an agreement with
the BC Liquor Distribution Branch ("BCLDB") to supply a number of its
products exclusively to British Columbia.
The
agreement was entered into after the BC
Liquor Distribution Branch (BCLDB) met with THC BioMed management and
toured THC's flagship facility in Kelowna B.C.
The BCLDB will provide purchase orders to
THC BioMed for the product quantities listed in the appendix to the agreement
three months in advance of the available supply month.
● THC BioMed Ltd. has committed to:
○ Supplying all produced dried flower product
intended for the non-medical market, exclusively to the BCLDB until December
2019;
○ Maintaining Wholesale Cost incl. Excise as
listed in the appendix to the Agreement until December 2019; and
○ Supplying the product as per the quantities
and schedule listed in the appendix to the Agreement.
THC
BioMed has agreed to exclusively supply the BCLDB with several flower strains
in 3.5-gram and 7-gram formats until December 2019.
"We
are proud that our products will be featured in our home province of BC. We
continue to strive to produce cannabis products that are pure, clean and
potent. We also look forward to launching THC Kiss, a pure organically produced
cannabis beverage, when regulations permit" commented John Miller, CEO and
president of THC BioMed.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...